Hypertension Trial, Recruiting NCT03496792 Sponsor: Milton S. Hershey Medical Center Condition: Hypertension
Back to Hypertension

Hypertension Trial, Recruiting

NCT03496792
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are able to give their own informed consent to take part
  • People of any race or ethnicity
  • People who are fluent in both written and spoken English
  • People whose health history and physical examination do not reveal any of the exclusion conditions listed below
  • People who are 18 years of age or older

For people with higher blood pressure when standing:

  • People whose blood pressure when standing is at least 10 mmHg higher than when lying down
  • People diagnosed with Stage 1 high blood pressure (a mild form of high blood pressure) who do not have other ongoing health conditions

For healthy people without higher blood pressure when standing:

  • People whose blood pressure does not change significantly when moving from lying down to standing (within 5 mmHg either way)
  • People who are a similar gender, age, and body size (within 10%) to participants with elevated standing blood pressure
  • People who are free from any short-term or long-term medical conditions

Who may not be able to join:

  • People under 18 years of age
  • People who are pregnant or currently breastfeeding
  • People who are prisoners, living in an institution, or otherwise unable to give their own consent
  • People with ongoing health conditions such as heart disease, lung disease, neuromuscular disease, or cancer (Stage 1 high blood pressure is the only exception)
  • People who experience a significant drop in blood pressure when standing up, or who have a history of fainting
  • People who currently smoke
  • People with a history of blood clots

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 12 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Jian Cui, Penn State College of Medicine

Phone: 717-531-1799

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Milton S. Hershey Medical Center
Registry
ClinicalTrials.gov
Start date
10 March 2020
Est. completion
1 November 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Muscle Sympathetic Nerve Activity (MSNA) in bursts/min or arbitrary units/min

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov